Literature DB >> 14769198

Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.

Lian-qing Guo1, Yasushi Yamazoe.   

Abstract

Furanocoumarins (psoralens) exist in various plants and some of them are used to cure skin diseases. These chemicals draw attentions recently because of their abilities to arouse drug interaction through inhibition of cytochrome P450. Grapefruit juice is a well-known example for food-drug interaction. But in vitro and in vivo studies have shown that the causative components are mainly furanocoumarin derivatives with geranyloxy side chains. In vitro experiments confirmed that furanocoumarins from grapefruit juice are both competitive and mechanism-based inhibitors of CYP3A4. Although the inhibition appeared to be stronger in the dimers than that in the monomers, all contribute comprehensively to the grapefruit juice-drug interaction. Further experiments with other furanocoumarins and related citrus fruits or umbelliferous herbal medicines indicate that drug interaction might also occur with stuffs other than grapefruit juice, especially with traditional medicine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769198

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  21 in total

Review 1.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Effects of naturally occurring coumarins on hepatic drug-metabolizing enzymes in mice.

Authors:  Heather E Kleiner; Xiaojun Xia; Junichiro Sonoda; Jun Zhang; Elizabeth Pontius; Jane Abey; Ronald M Evans; David D Moore; John DiGiovanni
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-15       Impact factor: 4.219

Review 3.  Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues.

Authors:  Worku Abebe
Journal:  EPMA J       Date:  2019-01-08       Impact factor: 6.543

Review 4.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

5.  Coordinated roles of pregnane X receptor and constitutive androstane receptor in autoinduction of voriconazole metabolism in mice.

Authors:  Masato Ohbuchi; Kouichi Yoshinari; Hayato Kaneko; Satoru Matsumoto; Akiko Inoue; Akio Kawamura; Takashi Usui; Yasushi Yamazoe
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

6.  Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

Authors:  Yune-Fang Ueng; Chien-Chih Chen; Yu-Ting Chung; Tsung-Yun Liu; Yu-Ping Chang; Wei-Sheng Lo; Norie Murayama; Hiroshi Yamazaki; Pavel Souček; Gar-Yang Chau; Chin-Wen Chi; Ruei-Ming Chen; Ding-Tzai Li
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 7.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

8.  Controlled inactivation of recombinant viruses with vitamin B2.

Authors:  Shellie M Callahan; Piyanuch Wonganan; Linda J Obenauer-Kutner; Suganto Sutjipto; Joseph D Dekker; Maria A Croyle
Journal:  J Virol Methods       Date:  2007-12-21       Impact factor: 2.014

9.  The Significance of Drug-Drug and Drug-Food Interactions of Oral Anticoagulation.

Authors:  Pascal Vranckx; Marco Valgimigli; Hein Heidbuchel
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03

10.  Effect of blueberry juice on clearance of buspirone and flurbiprofen in human volunteers.

Authors:  Michael J Hanley; Gina Masse; Jerold S Harmatz; Paul F Cancalon; Gregory G Dolnikowski; Michael H Court; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.